Latest
Hot
1.The global market space for weight-loss drugs exceeds 100 billion dollars.
Wegovy, which has sparked discussions on social media, is a GLP-1 receptor agonist medication. GLP-1 drugs have now become a goldmine for pharmaceutical giants Novo Nordisk and Eli Lilly, propelling Novo Nordisk to become the most valuable company in Europe, surpassing LVMH Group.
It is said that by sticking to a weekly injection, weight can be...
Wegovy, which has sparked discussions on social media, is a GLP-1 receptor agonist medication. GLP-1 drugs have now become a goldmine for pharmaceutical giants Novo Nordisk and Eli Lilly, propelling Novo Nordisk to become the most valuable company in Europe, surpassing LVMH Group.
It is said that by sticking to a weekly injection, weight can be...
+3
7
2
Market Macro: Global Stock Markets Suffered a "Black Thursday"
The highly anticipated September interest rate decision was announced on Wednesday, with the benchmark interest rate held steady at its highest point in 22 years, between 5.25% and 5.50%, meeting market expectations.
However, the dot plot unexpectedly leaned towards a hawkish stance, suggesting another rate hike this year, a halving of rate c...
The highly anticipated September interest rate decision was announced on Wednesday, with the benchmark interest rate held steady at its highest point in 22 years, between 5.25% and 5.50%, meeting market expectations.
However, the dot plot unexpectedly leaned towards a hawkish stance, suggesting another rate hike this year, a halving of rate c...
+3
14
1
It is expected that GLP-1 category will reach well over $100bn in annual sales over time. This is driven fairly equally by diabetes/obesity usage and we would not be surprised to see further upside to our numbers in both indications over time. And with LLY/ Novo expected to continue to roughly split the market, it is expected that LLY’s GLP-1 sales increasing from ~$8bn in 2022 to ~$23bn in...
6
Weight-loss drug stocks are the big winners in the market as investors got clear evidence that these drugs could be a game-changer for the pharmaceutical industry. While other companies—including those outside of healthcare—could feel a more negative impact.
Morgan Stanley anticipated annual global sales for weight-loss drugs could reach $77 billion by 2030, higher than its previous $54 billion forecast. $Novo-Nordisk A/S(NVO.US$ and $Eli Lilly and Co(LLY.US$ will spli...
Morgan Stanley anticipated annual global sales for weight-loss drugs could reach $77 billion by 2030, higher than its previous $54 billion forecast. $Novo-Nordisk A/S(NVO.US$ and $Eli Lilly and Co(LLY.US$ will spli...
33
2
products”. If every retail customer follows suit, then let's see when they will sell “regret medicine” for them to eat.
The survey found the drug didn’t impact appetite for all foods uniformly. In fact, there was a 46 per cent increase in patients saying they were consuming more fruit and veg.
this was bad news for companies such as $Mondelez International(MDLZ.US$ , $Hershey(HSY.US$ , $Domino's Pizza(DPZ.US$ and $McDonald's(MCD.US$ . Some AOM patients were also foregoing alcohol consumption entirely, which was seen as a headwind for beer brand $MOLSON COORS CANADA INC(MXGBF.US$ . However...
this was bad news for companies such as $Mondelez International(MDLZ.US$ , $Hershey(HSY.US$ , $Domino's Pizza(DPZ.US$ and $McDonald's(MCD.US$ . Some AOM patients were also foregoing alcohol consumption entirely, which was seen as a headwind for beer brand $MOLSON COORS CANADA INC(MXGBF.US$ . However...
1
Rx DOMAIN TV: HEALING THE GLOBAL MEDIA...ONE DANCE AND ONE WEIGHT LIFT SQUAT AT A TIME...💃💃💃..🏋️🏋️🏋️
We need to seriously start pushing a healthy lifestyle... We can't afford to be PC anymore ..don't give the government another reason to justify killing us...☠️☠️☠️
1
G'day, mooers! Check out the latest news on today's stock market!
• Investors head into fall with jitters after summer rally
• ASX opens lower; ResMed, Macquarie sink
• Stocks to watch: Orora, Macquarie, ResMed
- Moomoo News AU
Wall Street Summary
Major stock indexes on Wall Street closed lower, giving back some of their recent gains as traders returned from a long holiday weekend.
The $S&P/ASX 200(.XJO.AU$ fell 0.4 per cent, whil...
• Investors head into fall with jitters after summer rally
• ASX opens lower; ResMed, Macquarie sink
• Stocks to watch: Orora, Macquarie, ResMed
- Moomoo News AU
Wall Street Summary
Major stock indexes on Wall Street closed lower, giving back some of their recent gains as traders returned from a long holiday weekend.
The $S&P/ASX 200(.XJO.AU$ fell 0.4 per cent, whil...
4
In response to the news of Novo Nordisk's weight loss wonder drug Wegovy entering the UK market, Novo Nordisk's stock price closed up by 0.7%, reaching a market capitalization of $428 billion. Meanwhile, luxury goods giant LVMH Group's stock price dropped by 0.4%, with a market cap of approximately $419 billion.
Novo Nordisk announced on Monday that it would introduce Wegovy to the UK market through a "control...
Novo Nordisk announced on Monday that it would introduce Wegovy to the UK market through a "control...
6
Here's a list of the top 40 non-US companies from the MSCI Quality Index.
What do you think the best non-US companies are?
$Berkshire Hathaway 13F(BK2999.US$ $Berkshire Hathaway-A(BRK.A.US$ $Berkshire Hathaway-B(BRK.B.US$ $BHP Group Ltd(BHP.AU$ $NOVO NORDISK A/S(NONOF.US$ $ASML Holding(ASML.US$ $Occidental Petroleum(OXY.US$ $Bank of America(BAC.US$
What do you think the best non-US companies are?
$Berkshire Hathaway 13F(BK2999.US$ $Berkshire Hathaway-A(BRK.A.US$ $Berkshire Hathaway-B(BRK.B.US$ $BHP Group Ltd(BHP.AU$ $NOVO NORDISK A/S(NONOF.US$ $ASML Holding(ASML.US$ $Occidental Petroleum(OXY.US$ $Bank of America(BAC.US$
1
104284992 : Deep Analysis
Noah JohnsonOP 104284992: